ALISO VIEJO, Calif., Dec. 3, 2019 /PRNewswire/ — Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for lumbar spinal stenosis (LSS), today announced the completion of enrollment in its nationwide, multicenter MOTION Study of its mild® Procedure. The novel prospective, randomized controlled study will collect clinically validated, patient-reported pain and function outcome measures, as …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone